News Releases

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

December 21, 2020

Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing

December 14, 2020

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

December 1, 2020

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

November 23, 2020

Anixa Biosciences to Host Conference Call to Provide Update on Programs

October 27, 2020

Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

September 8, 2020

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

August 13, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

July 28, 2020

Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

July 20, 2020

Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office

July 10, 2020

Latest News & Events

Jun 23, 2025

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Read More...

Jun 20, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Read More...

Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Read More...